Kyphoplasty Market Size
Kyphoplasty Market size was valued at USD 635 million in 2022 and is estimated to account for USD 1.1 billion by 2032. Kyphoplasty is a minimally invasive surgical procedure used to treat vertebral compression fractures (VCFs) in the spine, often caused by osteoporosis or spinal tumors.

The procedure involves the insertion of a balloon device into the fractured vertebra that influences to create a cavity. The cavity is filled with orthopedic bone cement and casting materials to stabilize the fractured vertebra, restore vertebral height, and alleviate pain. Thus, kyphoplasty caters as a minimally invasive alternative to standard spine surgery for patients associated with vertebral compression fractures with less pain and improve mobility, thereby increasing the adoption rate.
As osteoporosis becomes more prevalent, it's creating a surge in the market for medical treatments. According to the International Osteoporosis Foundation, a staggering number of people worldwide are affected by this bone-weakening condition. One in five men and one in three women over 50 have osteoporosis, particularly prevalent among women, with over 200 million cases globally. As we age, the risk of developing osteoporosis increases significantly. Among women over 60, one in ten has the condition, while for those over 70, it's one in five. Alarmingly, over 80% of women over 90 are affected. This growing prevalence is driving an increase in demand for medical devices and procedures to address osteoporosis. One procedure experiencing a boom is kyphoplasty, a surgery that treats spinal fractures caused by the condition. This surge in demand is shaping the medical device industry, providing new opportunities for companies specializing in osteoporosis treatments.
Kyphoplasty Market Report Attributes
Report Attribute |
Details |
Base Year | 2022 |
---|
Kyphoplasty Market Size in 2022 | USD 635 Million |
---|
Forecast Period | 2023 to 2032 |
---|
Forecast Period 2023 to 2032 CAGR | 5.5% |
---|
2032 Value Projection | USD 1.1 Billion |
---|
Historical Data for | 2018 to 2022 |
---|
No. of Pages | 328 |
---|
Tables, Charts & Figures | 445 |
Segments covered | Product, Application, Indication, End-use, and Region |
---|
Growth Drivers | - Increasing patient preference towards minimally invasive procedures
- Technological advancements
- Growing prevalence of osteoporosis
- Upsurge in elderly population
|
---|
Pitfalls & Challenges | - Limited awareness and accessibility for kyphoplasty systems
- Risk associated with surgery
|
---|
COVID-19 Impact
The COVID-19 pandemic had a negative impact on the kyphoplasty market. The pandemic disrupted global supply chains that led to shortages of medical products, including kyphoplasty devices. This caused price fluctuations and delayed delivery times, which impacted the availability of these products in some regions. Moreover, the pandemic caused the delay or cancellation of several elective operations and treatments, including kyphoplasty. This resulted in a decline in the overall number of kyphoplasty surgeries done during the pandemic's peak. Therefore, COVID-19 pandemic hindered the market revenue.
Kyphoplasty Market Trends
Advances in kyphoplasty techniques are driving the demand for these devices. New designs for bone tamps, cement delivery systems, and navigation technologies make kyphoplasty more effective and easier to use. Also, healthcare facilities are using more advanced imaging technologies like fluoroscopy, CT scans, bone densitometers, and intraoperative navigation systems during these procedures. This helps doctors see better and guide their instruments, cement injections, and overall surgeries more accurately. These improvements have made kyphoplasty devices more popular, which is why the market for these devices is expected to keep growing.
Kyphoplasty Market Analysis
Based on product, the kyphoplasty market is bifurcated into balloon catheters, bone access devices, bone cement, cement mixing systems, and instruments. The bone access devices segment held the largest revenue share accounting for USD 236.7 million in 2022. The increasing incidence rate of vertebral compression fractures often associated with osteoporosis and spinal tumors will drive the demand for bone access devices as the awareness and diagnosis of these conditions improve, the need for effective bone access devices to perform kyphoplasty procedures also increases.
Moreover, the increasing demand for minimally invasive procedures in the field of spine surgery will spur the need for specialized bone access devices. These devices enable surgeons to create small incisions and access the fractured vertebrae with minimal tissue disruption, reducing patient trauma, postoperative pain, and recovery time thereby accelerating segmental revenue growth.
Based on application, the kyphoplasty market is classified into vertebral alignment restoration, spinal fractures, and kyphosis. The spinal fractures segment dominated the market and is anticipated to witness over USD 590 million by 2032. Rising rates of compressed spine bones owing to malignancy and trauma will propel the market expansion capabilities. Additionally, the global increase in the aging population base plays a significant role in driving the spinal fractures segment as older individuals are more susceptible to conditions such as osteoporosis that leads to vertebral fractures.
The world of kyphoplasty, a procedure that repairs spinal fractures, has two main playersosteoporosis and other conditions. Osteoporosis, a condition that weakens bones, is the biggest reason for kyphoplasty. In 2022, it was a money-maker, raking in over $411 million. And the future looks even brighter as more people, especially seniors, develop osteoporosis. Broken bones from osteoporosis, particularly those in the spine, can be a major pain for patients and healthcare systems. So, the demand for effective treatments for these fractures is fueling the growth of the osteoporosis segment in the kyphoplasty market.
Hey! If you're struggling with a nagging backache and your doc has suggested a procedure called kyphoplasty, you might be wondering where to head for it. Well, the majority of folks (like 70%) choose hospitals or clinics. Why? Because these places are like well-equipped fortresses, packed with fancy X-ray and imaging gadgets. Plus, they've got experienced doctors and nurses who know their stuff. They can do kyphoplasty with tiny cuts, which makes it less painful and risky for you. And here's the kickerhospitals and clinics often take insurance and Medicare. That means you can save some precious pennies out of your own pocket. All these perks have made hospitals and clinics the rockstars of kyphoplasty, making them the go-to destinations for this procedure.

Moreover, the preference for minimally invasive procedures in the U.S. is another major aspect propelling the market growth. The minimally invasive kyphoplasty techniques offers several advantages such as smaller incisions, reduced tissue trauma, shorter hospital stays, and faster recovery compared to traditional open surgery thereby bolstering market demand. Furthermore, the strong presence of business players, favourable reimbursement policies and insurance coverage are few other aspects boosting market progression in near future.
Kyphoplasty Market Share
Some of the prominent market participants operating in the kyphoplasty market include
- Stryker
- MicroPort Scientific Corporation
- Medtronic Inc.
- DePuy Synthes (Johnson & Johnson Services Inc.)
- Smith & Nephew
- IZI Medical Products
- Merit Medical Systems
- CareFusion
- Joimax GmbH
- Joline GmbH & Co. KG
- G21 S.r.l.
- iMEDICOM
- Seawon MeditechTaeyeon Medical Co., Ltd.
- Hensler Surgical Products
- Jiangsu ChangMei Medtech Co., Ltd
These market players are undertaking several growth strategies including partnerships, collaborations, acquisitions & mergers, and new product development & launches to strengthen their product portfolio as well as gain a competitive edge over others.
Kyphoplasty Industry News
- In April 2022, Nanox announced that they received approval for the HealthOST device from U.S. FDA. HealthOST is an AI software that monitors vertebral compression fractures and poor bone density to detect osteoporosis conditions. Such advancements in medical diagnostic devices helped the company to gain competitive advantage over its peers.
- In August 2021, IZI Medical Products introduced Vertefix HV cement, a cutting-edge device for kyphoplasty and vertebroplasty surgeries that provides real-time flow visualization during cement injection in kyphoplasty. This broadened the company’s product offerings in the significant market.
Kyphoplasty market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments
Click here to Buy Section of this Report
Market, By Product (USD Million & Units)
- Balloon catheters
- Bone access devices
- Bone cement
- Cement mixing systems
- Instruments
Market, By Application (USD Million)
- Vertebral alignment restoration
- Spinal fractures
- Kyphosis
Market, By Indication (USD Million)
Market, By End-use (USD Million)
- Hospitals & clinics
- Ambulatory surgical centers
- Others
The above information is provided for the following regions and countries
- North America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Switzerland
- The Netherlands
- Denmark
- Poland
- Sweden
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- New Zealand
- Thailand
- Vietnam
- Indonesia
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
- Middle East & Africa
- Saudi Arabia
- South Africa
- UAE
- Turkey